supporting image

Leadership

We are passionate about continuing our legacy.

For over 50 years, our discoveries and insights have shattered the norm and helped make real, meaningful differences for people around the world. Our leaders help inform both our purpose and progress.

 

Executive Team

Adam Schechter 

Chairman, President and Chief Executive Officer

Global business leader Adam Schechter became Chief Executive Officer of Labcorp in 2019 and Chairman of the Board in May 2020.

Amy Summy

Executive Vice President and Chief Marketing Officer

Amy Summy has served as Executive Vice President and Chief Marketing Officer since March 2020.

Brian Caveney, M.D., J.D., M.P.H.

Executive Vice President, President, Diagnostics and Chief Medical Officer

Dr. Brian Caveney has served as Executive Vice President, President, Diagnostics and Chief Medical Officer at Labcorp since 2019.

Glenn Eisenberg

Executive Vice President and Chief Financial Officer

Glenn Eisenberg has served as Executive Vice President and Chief Financial Officer of Labcorp since 2014. 

Judith (Judi) Seltz

Executive Vice President and Chief Human Resources Officer

Judi Seltz has served as Executive Vice President and Chief Human Resources Officer since February 2020.

Lance Berberian

Executive Vice President and Chief Information and Technology Officer

Lance Berberian has served as Executive Vice President and Chief Information and Technology Officer since 2014. 

Mark Schroeder 

Executive Vice President and President, Diagnostics Laboratory Operations and Global Supply Chain

Mark Schroeder became Executive Vice President and President of Diagnostics Laboratory Operations and Global Supply Chain in 2019. 

Paul Kirchgraber, M.D.

Executive Vice President and Chief Executive Officer Early Development, Central Laboratories and Global Oncology

Dr. Paul Kirchgraber has served as Executive Vice President and Chief Executive Officer of Labcorp Drug Development since 2019.

Sandra (Sandy) van der Vaart, J.D.

Executive Vice President, Chief Legal Officer, Chief Compliance Officer and Corporate Secretary

Sandy van der Vaart has served as Executive Vice President, Chief Legal Officer, Chief Compliance Officer and Corporate Secretary since February 2020.

Thomas (Tom) Pike

President and CEO, Clinical Development

Thomas (Tom) Pike was appointed to serve as president and chief executive officer of Labcorp Drug Development’s Clinical Development business unit in January 2023. At the time of the planned spin-off of the Clinical Development business, Pike will serve as the chief executive officer and chairman of the Board of the independent, publicly listed company.

Board of Directors

Adam Schechter 

Chairman, President and Chief Executive Officer

Global business leader Adam Schechter became Chief Executive Officer of Labcorp in 2019 and Chairman of the Board in May 2020.

Kerri B. Anderson

Director

Kerrii B. Anderson has served as a director of the Company since May 17, 2006.

Jean-Luc Bélingard

Director

Jean-Luc Bélingard has served as a director of the Company since April 28, 1995.

Jeffrey A. Davis

Director

Jeffrey A. Davis has served as a director of the Company since December 1, 2019. 

D. Gary Gilliland M.D., Ph.D.

Director

D. Gary Gilliland has served as a director of the Company since April 1, 2014.

Kirsten Kliphouse

Director

Kirsten Kliphouse has served as a director of the Company since October 12, 2022.

Garheng Kong M.D., Ph.D.

Director

Garheng Kong has served as a director of the Company since December 1, 2013. 

Peter M. Neupert

Director

Peter M. Neupert has served as a director of the Company since January 1, 2013.

Richelle P. Parham

Director

Richelle Parham has served as a director of the Company since February 8, 2016.

Kathryn E. Wengel

Director

Kathryn E. Wengel has served as a director of the Company since March 25, 2021.

R. Sanders Williams, M.D.

Director

Dr. R. Sanders Williams has served as a director of the Company since May 16, 2007.

Setting a vision for improving health, improving lives 

Our board of directors and the executive team members lead our strategic vision and purpose to improve health, improve lives.

One key responsibility of these teams is to understand and improve the company's focus on environmental, social and governance (ESG) efforts.

The ESG steering committee, comprised of cross-functional senior management members, helps to set the overall ESG strategy and recommend policies, practices, disclosures, and short- or long-term company initiatives.